Yannick Le Bris (Yanick Le Bris)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 21

Top Topics

Acute Myeloid Leukemia

Stem Cell Transplantation

Top Venues

American journal of hematology

International journal of laboratory hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marion Eveillard, Yannick Le Bris, Simon Bouzy, Benoît Tessoulin, Thomas Gastinne, Viviane Dubruille, Cyrille Touzeau, Béatrice Mahé, Nicolas Blin, Anne Lok, Sophie Vantyghem, Clara Sortais, Chloé Antier, Phillipe Moreau, Emmanuel Scotet, Marie C Béné, Patrice Chevallier
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide. American journal of hematology 99 (3) (2024)
Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marion Eveillard, Yannick Le Bris, Simon Bouzy, Benoît Tessoulin, Thomas Gastinne, Viviane Dubruille, Cyrille Touzeau, Béatrice Mahé, Nicolas Blin, Anne Lok, Sophie Vantyghem, Clara Sortais, Chloé Antier, Phillipe Moreau, Emmanuel Scotet, Marie C Béné, Patrice Chevallier
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide. American journal of hematology 99 (3) (2024)
Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marion Eveillard, Yannick Le Bris, Simon Bouzy, Benoît Tessoulin, Thomas Gastinne, Viviane Dubruille, Cyrille Touzeau, Béatrice Mahé, Nicolas Blin, Anne Lok, Sophie Vantyghem, Clara Sortais, Chloé Antier, Phillipe Moreau, Emmanuel Scotet, Marie C Béné, Patrice Chevallier
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide. American journal of hematology 99 (3) (2024)
Cédric De Almeida Braga, Maxence Bauvais, Pierre Sujobert, Mael Heiblig, Maxime Jullien, Baptiste Le Calvez, Camille Richard, Valentin Le Roc'h, Emmanuelle Rault, Olivier Hérault, Pierre Peterlin, Alice Garnier, Patrice Chevallier, Simon Bouzy, Yannick Le Bris, Antoine Néel, Julie Graveleau, Olivier Kosmider, Perrine Paul-Gilloteaux, Nicolas Normand, Marion Eveillard
Deep Learning-Based Blood Abnormalities Detection as a Tool for VEXAS Syndrome Screening. International journal of laboratory hematology (2024)
Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marion Eveillard, Yannick Le Bris, Simon Bouzy, Benoît Tessoulin, Thomas Gastinne, Viviane Dubruille, Cyrille Touzeau, Béatrice Mahé, Nicolas Blin, Anne Lok, Sophie Vantyghem, Clara Sortais, Chloé Antier, Phillipe Moreau, Emmanuel Scotet, Marie C Béné, Patrice Chevallier
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide. American journal of hematology (2024)
Salomé Decombis, Celine Bellanger, Yannick Le Bris, Candice Madiot, Jane Jardine, Juliana Carvalho Santos, Delphine Boulet, Christelle Dousset, Audrey Menard, Charlotte Kervoelen, Elise Douillard, Philippe Moreau, Stephane Minvielle, Agnes Moreau-Aubry, Benoît Tessoulin, Gael Roue, Nicolas Bidère, Steven Le Gouill, Catherine Pellat-Deceunynck, David Chiron
CARD11 gain of function upregulates BCL2A1 and promotes resistance to targeted therapies combination in B-cell lymphoma. Blood (2023)
Romane Durand, Geraldine Descamps, Christelle Dousset, Celine Bellanger, Sophie Maïga, Jean-Baptiste Alberge, Jennifer Derrien, Jonathan Cruard, Stephane Minvielle, Nicoletta Libera Lilli, Catherine Godon, Yannick Le Bris, Benoît Tessoulin, Martine Amiot, Patricia Gomez-Bougie, Cyrille Touzeau, Philippe Moreau, David Chiron, Agnes Moreau-Aubry, Catherine Pellat-Deceunynck
A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals major role of BAX in BH3 mimetics response. Blood (2023)
Jérome Tamburini, Sarah Mouche, Clement Larrue, Nicolas Duployez, Audrey Bidet, Auriane Salotti, Pierre Hirsch, Lucie Rigolot, Sylvain Carras, Marie Temple, Fabrizia Favale, Pascale Flandrin-Gresta, Yannick Le Bris, Anne-Sophie Alary, Laurent Mauvieux, Sylvie Tondeur, Eric Delabesse, Francois Delhommeau, Pierre Sujobert, Olivier Kosmider
Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia. Blood advances (2023)
Mathieu Simonin, Guillaume P Andrieu, Rudy Birsen, Marie Balsat, Guillaume Hypolite, Lucien Courtois, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Françoise Huguet, Yves Chalandon, Yannick Le Bris, Elizabeth A Macintyre, Virginie Gandemer, Arnaud Petit, Philippe Rousselot, André Baruchel, Didier Bouscary, Olivier Hermine, Nicolas Boissel, Vahid Asnafi
Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL. Blood 141 (11) (2023)
Mathieu Simonin, Guillaume P Andrieu, Rudy Birsen, Marie Balsat, Guillaume Hypolite, Lucien Courtois, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Françoise Huguet, Yves Chalandon, Yannick Le Bris, Elizabeth A Macintyre, Virginie Gandemer, Arnaud Petit, Philippe Rousselot, André Baruchel, Didier Bouscary, Olivier Hermine, Nicolas Boissel, Vahid Asnafi
Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL. Blood 141 (11) (2023)
Mathieu Simonin, Guillaume P Andrieu, Rudy Birsen, Marie Balsat, Guillaume Hypolite, Lucien Courtois, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Françoise Huguet, Yves Chalandon, Yannick Le Bris, Elizabeth A Macintyre, Virginie Gandemer, Arnaud Petit, Philippe Rousselot, André Baruchel, Didier Bouscary, Olivier Hermine, Nicolas Boissel, Vahid Asnafi
Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL. Blood (2023)
Mathieu Simonin, Guillaume P Andrieu, Rudy Birsen, Marie Balsat, Guillaume Hypolite, Lucien Courtois, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Françoise Huguet, Yves Chalandon, Yannick Le Bris, Elizabeth A Macintyre, Virginie Gandemer, Arnaud Petit, Philippe Rousselot, André Baruchel, Didier Bouscary, Olivier Hermine, Nicolas Boissel, Vahid Asnafi
Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL. Blood (2023)
Yannick Le Bris, Adeline Normand, Louise Bouard, Audrey Ménard, Céline Bossard, Anne Moreau, Marie C Béné
Aggressive, early resistant and relapsed mantle cell lymphoma distinct extrinsic microenvironment highlighted by transcriptome analysis. EJHaem 3 (4) (2022)
Nicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, Rathana Kim, Julie Rieunier, Juliette Lambert, Audrey Bidet, Lise Larcher, Jean Lemoine, François Delhommeau, Pierre Hirsch, Laurène Fenwarth, Olivier Kosmider, Justine Decroocq, Anne Bouvier, Yannick Le Bris, Marlène Ochmann, Alberto Santagostino, Lionel Ades, Pierre Fenaux, Xavier Thomas, Jean-Baptiste Micol, Claude Gardin, Raphaël A Itzykson, Jean Soulier, Emmanuelle Clappier, Christian Recher, Claude Preudhomme, Arnaud Pigneux, Hervé Dombret, Eric Delabesse, Marie Sébert
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study. Blood 140 (7) (2022)
Yannick Le Bris, Domitille Costes, Raphaël Bourgade, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Patrice Chevallier, Marie Christine Bene
Impact on outcomes of mixed chimerism of bone marrow CD34+ sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid malignancies. Bone marrow transplantation 57 (9) (2022)
Corentin Bassi, Pierre Peterlin, Marie Christine Bene, Yannick Le Bris, Marion Eveillard
Fortuitous discovery of an NPM1 mutation in a myelodysplastic syndrome. International journal of laboratory hematology 43 (6) (2021)
Camille Debord, Soraya Wuillème, Marion Eveillard, Olivier Theisen, Catherine Godon, Yannick Le Bris, Marie Christine Bene
Flow cytometry in the diagnosis of mature B-cell lymphoproliferative disorders. International journal of laboratory hematology (2021)
Sophie Allain-Maillet, Adrien Bosseboeuf, Nicolas Mennesson, Mégane Bostoën, Laura Dufeu, Eun Ho Choi, Cédric Cleyrat, Olivier Mansier, Eric Lippert, Yannick Le Bris, Jean-Marc Gombert, François Girodon, Magali Pettazzoni, Edith Bigot-Corbel, Sylvie Hermouet
Anti-Glucosylsphingosine Autoimmunity, JAK2V617F-Dependent Interleukin-1β and JAK2V617F-Independent Cytokines in Myeloproliferative Neoplasms. Cancers 12 (9) (2020)
Camille Debord, Jessie Bourcier, François Subiger, François Leclair, Cyrille Touzeau, Thomas Gastinne, Anne Moreau, Olivier Theisen, Catherine Godon, Nelly Robillard, Yannick Le Bris, Marie Christine Bene, Soraya Wuillème
Fluctuating plasmacytosis in an immunocompetent woman leading a diagnosis of plasmablastic lymphoma. Annals of hematology 100 (1) (2020)
Baptiste Le Calvez, Yannick Le Bris, Guillaume Herbreteau, Bastien Jamet, Céline Bossard, Benoît Tessoulin, Thomas Gastinne, Béatrice Mahé, Viviane Dubruille, Nicolas Blin, Chloé Antier, Olivier Theisen, Françoise Kraeber-Bodéré, Steven Le Gouill, Marie C Béné, Philippe Moreau, Cyrille Touzeau
RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutation. EJHaem 1 (1) (2020)
Yannick Le Bris, Florence Magrangeas, Anne Moreau, David Chiron, Catherine Guérin-Charbonnel, Olivier Theisen, Olivier Pichon, Danielle Canioni, Barbara Burroni, Hervé Maisonneuve, Catherine Thieblemont, Lucie Oberic, Emmanuel Gyan, Catherine Pellat-Deceunynck, Olivier Hermine, Marie-Hélène Delfau-Larue, Benoît Tessoulin, Marie Christine Bene, Stéphane Minvielle, Steven Le Gouill
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group. Hematological oncology 38 (4) (2020)